Establishment Labs Holdings, Inc. (ESTA)
71.14
-0.34
(-0.48%)
USD |
NASDAQ |
Sep 16, 16:00
71.14
0.00 (0.00%)
After-Hours: 16:18
Establishment Labs Holdings Enterprise Value : 2.322B for Sept. 15, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 2.322B |
| September 14, 2026 | 2.335B |
| September 11, 2026 | 2.306B |
| September 10, 2026 | 2.319B |
| September 09, 2026 | 2.412B |
| September 08, 2026 | 2.436B |
| September 04, 2026 | 2.406B |
| September 03, 2026 | 2.347B |
| September 02, 2026 | 2.425B |
| September 01, 2026 | 2.265B |
| August 31, 2026 | 2.258B |
| August 28, 2026 | 2.297B |
| August 27, 2026 | 2.332B |
| August 26, 2026 | 2.351B |
| August 25, 2026 | 2.342B |
| August 24, 2026 | 2.339B |
| August 21, 2026 | 2.358B |
| August 20, 2026 | 2.323B |
| August 19, 2026 | 2.438B |
| August 18, 2026 | 2.433B |
| August 17, 2026 | 2.475B |
| August 14, 2026 | 2.560B |
| August 13, 2026 | 2.445B |
| August 12, 2026 | 2.444B |
| August 11, 2026 | 2.406B |
| Date | Value |
|---|---|
| August 10, 2026 | 2.429B |
| August 07, 2026 | 2.499B |
| August 06, 2026 | 2.548B |
| August 05, 2026 | 2.911B |
| August 04, 2026 | 3.011B |
| August 03, 2026 | 2.957B |
| July 31, 2026 | 2.950B |
| July 30, 2026 | 2.978B |
| July 29, 2026 | 2.931B |
| July 28, 2026 | 2.931B |
| July 27, 2026 | 2.936B |
| July 24, 2026 | 2.943B |
| July 23, 2026 | 2.907B |
| July 22, 2026 | 2.989B |
| July 21, 2026 | 3.042B |
| July 20, 2026 | 2.976B |
| July 17, 2026 | 2.951B |
| July 16, 2026 | 2.942B |
| July 15, 2026 | 2.892B |
| July 14, 2026 | 2.772B |
| July 13, 2026 | 2.811B |
| July 10, 2026 | 2.815B |
| July 09, 2026 | 2.837B |
| July 08, 2026 | 2.814B |
| July 07, 2026 | 2.905B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| PROCEPT BioRobotics Corp. | 954.45M |
| Abbott Laboratories | 204.21B |
| AngioDynamics, Inc. | 610.95M |
| Alphatec Holdings, Inc. | 2.137B |
| AtriCure, Inc. | 2.766B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -11.75M |
| Revenue (Quarterly) | 67.54M |
| Total Expenses (Quarterly) | 79.29M |
| EPS Diluted (Quarterly) | -0.39 |
| Gross Profit Margin (Quarterly) | 70.64% |
| Profit Margin (Quarterly) | -17.39% |
| Earnings Yield | -1.83% |
| Normalized Earnings Yield | -1.829 |